Latest Research | Long Covid
Latest long COVID research explores persistent symptoms, underlying mechanisms, and potential treatments. Studies reveal multi-system impacts, including cardiovascular, neurological, and respiratory issues. Researchers are investigating biomarkers for diagnosis and effective therapeutic interventions. Emerging data suggest the importance of vaccination in reducing long COVID risk. Ongoing trials aim to identify targeted therapies to alleviate prolonged symptoms and improve patient outcomes.
A study on long Covid patients revealed persistent immune activation and potential virus presence in various organs even years after infection. The research utilized imaging techniques to identify immune activation in the brain, spinal cord, lungs, and gut wall. The findings suggest a need for further investigation into treatments targeting leftover virus and immunomodulating therapies....
A news article discusses the shift towards decentralized clinical trials (DCTs) for long COVID treatments, enabling patients to participate from home rather than traveling to clinical sites.....
with further research existing treatments targeting the eradication/reduction of these type of autoantibodies for Long COVID could be used and biomarkers (blood tests to show the presence of Long COVID) could be developed to identify these autoantibodies in Long Haulers who have these types of neurological symptoms, particularly those with chronic pain.
This study focuses on COVID-19's long-term effects include debilitating "long COVID" symptoms, impacting millions and highlighting similarities with other post-acute infectious syndromes like ME/CFS, necessitating further research and public health measures
A research paper has revealed that children and adolescents who have COVID-19 were at a higher risk of developing major kidney problems post COVID infection, even if they had no prior kidney disease...
Finding help can be difficult. We hope to remove a barrier by listing Long Covid Practioners for various Long Covid symptoms.
This is the first Paxlovid trial out looking at whether Paxlovid would work for Long COVID treatment with the thinking that if the theory of a viral reservoir, or viral persistence is causing the illness then a drug that reduces the virus should help reduce the symptoms. The results of this trial have been talked
Unite to Fight | We envision a world free of Long Covid & ME/CFS stigmatization, where every individual can thrive.
Diagnosing, measuring, and treating Long COVID is complicated, as it can present differently from person to person and persist for months or years
Functional limitations and cardiovascular symptoms in long COVID. This research focuses on investigating long COVID, particularly the cardiovascular symptoms and functional limitations associated with the condition.